Ingestible Biosensors for Real-Time Medical Adherence Monitoring: MyTMed.

Ingestible Biosensors for Real-Time Medical Adherence Monitoring: MyTMed.
复制标题

DOI:
10.1109/hicss.2016.426
复制
发表时间:
2016-01
期刊:
Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences
影响因子:
--
通讯作者:
Boyer EW
Boyer EW
中科院分区:
其他
文献类型:
--
作者:
Chai PR;Rosen RK;Boyer EW

文献摘要

被引文献

相似文献

药物不依从性使慢性病的管理和治疗复杂化。不依从药物治疗与显著的死亡率、加速疾病进展和增加医疗保健费用相关。我的/治疗/用药(MyTMed)是一种新型的依从性监测系统,可直接测量药物依从性/不依从性。MyTMed由1)一个带有射频发射器的“数字药丸”组成,射频发射器在与胃pH值接触时激活; 2)一个中继集线器,捕获射频信号并将其传输到3)一个基于云的服务器,通过双向接口连接患者和医生。在我们日益移动的世界中,MyTMed能够提供药物摄入数据,并在真实的时间内提供支持依从性的干预措施。我们描述了以患者为中心的设计MyTMed以及行为理论支持的接口架构。
Medication nonadherence complicates the management and treatment of chronic disease. Nonadherence to medications is associated with significant mortality, accelerated disease progression, and increased health care costs. My/Treatment/Medication (MyTMed) is a novel adherence monitoring system that obtains direct measures of medication adherence/nonadherence. MyTMed consists of 1) a “digital pill” with a radiofrequency emitter that activates on contact with gastric pH; 2) a relay Hub that captures the radiofrequency signal and transmits it to 3) a cloud based server that connects patient and physicians via a bidirectional interface. In our increasingly mobile world, MyTMed is able to provide medication ingestion data and deliver interventions in real time that support adherence. We describe the patient-centered design of MyTMed as well as the behavioral theory supporting the interface architecture.